Global Artificial Blood Substitute Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Artificial Blood Substitute Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Artificial blood refers to artificial blood cells and their functional substitutes. Its function, as the name suggests, is to replace real human blood to meet people"s demand for blood and make up for the current blood shortage.

According to our (Global Info Research) latest study, the global Artificial Blood Substitute market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of 21.9% during review period.

Artificial blood substitutes are used as oxygen therapy agents for emergency resuscitation and disease treatment. They have very important practical significance in developing countries and field hospitals that lack blood and urgently need blood transfusion, lack refrigeration equipment, and even on the battlefield. At the same time they do have great potential in reducing the spread of infectious diseases and providing new options for religious people who refuse blood transfusions.

Despite the huge application prospects, these artificial blood products all face some common problems. In addition to the safety and efficacy to be verified by clinical trials, the current production scale still needs to be greatly increased, and the production cost needs to be greatly reduced to meet the future demand for artificial blood .

This report is a detailed and comprehensive analysis for global Artificial Blood Substitute market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Artificial Blood Substitute market size and forecasts, in consumption value ($ Million), 2019-2030

Global Artificial Blood Substitute market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Artificial Blood Substitute market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Artificial Blood Substitute market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Artificial Blood Substitute

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Artificial Blood Substitute market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aurum Biosciences Ltd., HEMARINA SA, HbO2 Therapeutics, KaloCyte Inc., SpheriTech Ltd., NuvOx Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Artificial Blood Substitute market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Artificial Blood Substitute market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Perfluorocarbon-based Oxygen Carrier (PFBOC)
Hemoglobin-based Oxygen Carrier (HBOC)

Market segment by Application
Military
Civil

Market segment by players, this report covers
Aurum Biosciences Ltd.
HEMARINA SA
HbO2 Therapeutics
KaloCyte Inc.
SpheriTech Ltd.
NuvOx Pharma

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Artificial Blood Substitute product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Artificial Blood Substitute, with revenue, gross margin, and global market share of Artificial Blood Substitute from 2019 to 2024.

Chapter 3, the Artificial Blood Substitute competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Artificial Blood Substitute market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Blood Substitute.

Chapter 13, to describe Artificial Blood Substitute research findings and conclusion.